Acknowledgments

EARLY DETECTION OF COLORECTAL CANCER IN BLOOD BASED ON LATEST GENERATION BIOMARKERS AND ARTIFICIAL INTELLIGENCE TOOLS” – ColoDix project has received the support of the EIC program from the European Commission under grant agreement No, 190177779

“ColoFast project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 767419”

The Spanish Ministry of Science and Innovation granted a TORRES QUEVEDO Project to Advanced Marker Discovery, S.L. with reference PTQ-11-04492, that is co-financed by the European Social Fund.

AMX Data – Identification of risk factors for the development of colorectal cancer and / or premalignant lesions using Big Data tools and Artificial Intelligence for Early Cancer Detection” has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 957099.

This company is capitalized by Innvierte, an investment program of CDTI, E.P.E.

Advanced Marker Discovery, S.L. has received a grant from EIT Health – European Institute of Innovation and Technology, for the project “Disruptive and high accuracy test for early colon cancer detection”, with Subgranting Agreement No 2020 Digital Sandbox – DS20-12416.

Advanced Marker Discovery, S.L. has received a grant from the Enterprise Competitiveness Institute (ICE), which is co-financed with the European Union FEDER funds, for the project “BigDatCancer”, with reference 04/18/VA/0108 for the project “Development of an algorithm for early detection of colon cancer based on risk factors identified using big data and artificial intelligence tools and molecular markers”.

Advanced Marker Discovery, S.L. has received a grant from the Enterprise Competitiveness Institute (ICE), which is co-financed with the European Union FEDER funds, for the project “ALMATIC”, with reference CCTT4/20/VA/0010 for the project “Definition and development of algorithms for data analysis platform in maintenance, Predictive Quality and health problems”.

“AI4ICD – Identification of Colon Cancer risk factors using AI, has received funding from the European Union’s Horizon 2020 research and innovation programme within the framework of the AI4EU Project funded under grant agreement No 825619”.

The Spanish Ministry of Science and Innovation (MCIN) has awarded Advanced Marker Discovery a grant for a project under the TORRES QUEVEDO CALL 2020 programme with reference number PTQ2020-0100990 which is co-financed by the State Research Agency; the European Union and NextGenerationEU.

Advanced Marker Discovery, S.L. has received a grant from EIT Health – European Institute of Innovation and Technology, for the project “Disruptive and high accuracy test for early colon cancer detection”, with Subgranting Agreement No. 2021 Mentoring and Coaching Network 210805.

Advanced Marker Discovery, S.L. has received a grant co-financed by the European Regional Development Fund, to encourage the use of R&D and innovation services by SMEs, “Cheque Innovación” Program in the framework of the research and innovation strategy for smart specialization (RIS3), within the program of the Community of Madrid for the period 2014-2020, through the project “DEVELOPMENT OF A GENETIC SIGNATURE FOR EARLY AND DIFFERENTIAL DIAGNOSIS OF CANCER OF CANCER OF CANCER IN NON INVASIVE SAMPLE”.

ColoDix – Early detection of colorectal cancer in blood based on latest generation biomarkers and Artificial Intelligence tools” has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 190177779.

Advanced Marker Discovery, S.L. has received a grant for the project “Development of a genetic signature for the early and differential diagnosis of pancreatic cancer in a non-invasive sample” submitted to the “Cheque Innovación” program, aid co-financed by the European Regional Development Fund (FEDER) in the Framework of the “Research and Innovation Strategies for Smart Specialization” (RIS3) of the Comunidad de Madrid, for the period 2014-2020, with reference number 09/772037.9/21.

Let’s extend
people’s lives

Come and join us to Detect cancer in blood.